Entera Bio Ltd. (ENTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Entera Bio Ltd., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$3.10
+1.31% today
Market cap
$532M
Overall quality
54/100
Kronos AI 30-day
−25.6%
0 of 8 simulated paths end higher
Entera Bio Ltd. (ENTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $532M. It trades at $3.10, up 1.31% today. Its overall quality score is 54 out of 100, ranked against the whole US market. 4 analysts' average target of $10.00 implies +222.6% from today's price. Kronos AI's 30-day forecast is −25.6% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $9.00 – $11.00 |
| Analysts | 4 |
| Upside to average | +222.6% |
Kronos AI 30-day forecast
| Expected close | $2.28 (−25.6%) |
| Likely range | −38.1% … −21.5% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 82 |
| Growth | 45 |
| Overall | 54 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.